For example, the high mRNA level of MBOAT2 can increase the risk of poor prognosis of adrenocortical carcinoma, bladder urothelial carcinoma, head and neck squamous cell carcinoma HPV+, liver hepatocellular carcinoma, mesothelioma, pheochromocytoma, paraganglioma, uterine corpus endometrial carcinoma, and uveal melanoma. This evidence concerns the gene MBOAT2 and mesothelioma.